Angielski
Clinicians in their daily practice must therefore consider two different aspects regarding the patient's experience of DH. One is related to the patients discomfort and their need for an immediate pain resolution. The other is in regard to the entire spectra of events that may lead to a non pathological exposure of dentin tissue in the oral environment. Both of these aspects demand that the clinician has not only a wide range of knowledge and clinical experience in order to offer the best treatment and the corrective strategies to their patients. Furthermore it is essential that well-controlled randomised clinical studies are undertaken in order to investigate new materials and their properties under rigorous clinical conditions. Currently there does not appear to be an ideal desensitising product (which successfully mimics the natural tissue) that can be effectively utilised in both in-office and in OTC/at-home environments. It is therefore imperative that researchers responsible for the development of new materials direct their attention into areas of research with targeted formulations that can mimic and restore the natural structures of the tooth.
